Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bariatric Surgery | 69 | 2022 | 194 | 15.090 |
Why?
|
Bulimia Nervosa | 90 | 2020 | 108 | 13.960 |
Why?
|
Feeding and Eating Disorders | 99 | 2022 | 173 | 13.950 |
Why?
|
Bulimia | 116 | 2022 | 140 | 11.910 |
Why?
|
Obesity, Morbid | 55 | 2021 | 225 | 11.580 |
Why?
|
Binge-Eating Disorder | 62 | 2020 | 77 | 10.420 |
Why?
|
Feeding Behavior | 83 | 2021 | 324 | 10.320 |
Why?
|
Anorexia Nervosa | 95 | 2020 | 141 | 9.670 |
Why?
|
Weight Loss | 45 | 2021 | 229 | 7.610 |
Why?
|
Obesity | 51 | 2021 | 963 | 4.980 |
Why?
|
Gastric Bypass | 23 | 2021 | 110 | 4.600 |
Why?
|
Affect | 35 | 2019 | 386 | 4.540 |
Why?
|
Depression | 46 | 2020 | 473 | 3.640 |
Why?
|
Body Image | 36 | 2020 | 76 | 3.540 |
Why?
|
Adult | 318 | 2021 | 25648 | 3.380 |
Why?
|
Surveys and Questionnaires | 93 | 2022 | 2501 | 3.060 |
Why?
|
Body Mass Index | 67 | 2020 | 770 | 3.010 |
Why?
|
Female | 350 | 2021 | 44532 | 2.890 |
Why?
|
Mental Disorders | 19 | 2021 | 371 | 2.650 |
Why?
|
Humans | 430 | 2023 | 86643 | 2.570 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 42 | 2017 | 216 | 2.410 |
Why?
|
Compulsive Behavior | 22 | 2017 | 83 | 2.330 |
Why?
|
Psychotherapy | 16 | 2020 | 74 | 2.200 |
Why?
|
Hyperphagia | 22 | 2016 | 35 | 2.180 |
Why?
|
Middle Aged | 184 | 2020 | 25028 | 2.110 |
Why?
|
Adolescent | 144 | 2021 | 8981 | 2.110 |
Why?
|
Personality | 20 | 2019 | 134 | 2.060 |
Why?
|
Young Adult | 98 | 2021 | 5976 | 1.990 |
Why?
|
Quality of Life | 26 | 2018 | 1585 | 1.960 |
Why?
|
Male | 176 | 2021 | 40965 | 1.930 |
Why?
|
Substance-Related Disorders | 18 | 2021 | 394 | 1.900 |
Why?
|
Longitudinal Studies | 31 | 2021 | 1019 | 1.840 |
Why?
|
Impulsive Behavior | 17 | 2021 | 281 | 1.830 |
Why?
|
Psychiatric Status Rating Scales | 49 | 2017 | 487 | 1.670 |
Why?
|
Eating | 12 | 2018 | 166 | 1.590 |
Why?
|
Anxiety | 19 | 2020 | 287 | 1.580 |
Why?
|
Body Weight | 26 | 2017 | 459 | 1.560 |
Why?
|
Alcoholism | 11 | 2021 | 172 | 1.520 |
Why?
|
Emotions | 16 | 2021 | 341 | 1.500 |
Why?
|
Stress, Psychological | 13 | 2017 | 313 | 1.490 |
Why?
|
Gastroplasty | 6 | 2017 | 21 | 1.450 |
Why?
|
Exercise | 14 | 2016 | 315 | 1.450 |
Why?
|
Comorbidity | 43 | 2019 | 943 | 1.440 |
Why?
|
Antidepressive Agents | 11 | 2014 | 106 | 1.420 |
Why?
|
Psychotherapy, Group | 13 | 2015 | 33 | 1.380 |
Why?
|
Vomiting | 22 | 2016 | 193 | 1.340 |
Why?
|
Postoperative Period | 21 | 2019 | 303 | 1.270 |
Why?
|
Self Concept | 23 | 2020 | 133 | 1.250 |
Why?
|
Follow-Up Studies | 46 | 2021 | 3640 | 1.240 |
Why?
|
Child Abuse | 8 | 2021 | 78 | 1.170 |
Why?
|
Mood Disorders | 12 | 2017 | 81 | 1.150 |
Why?
|
Hunger | 6 | 2018 | 23 | 1.120 |
Why?
|
Models, Psychological | 15 | 2017 | 157 | 1.120 |
Why?
|
Psychometrics | 19 | 2022 | 327 | 1.110 |
Why?
|
Cognition | 13 | 2015 | 570 | 1.050 |
Why?
|
Personality Disorders | 14 | 2016 | 146 | 1.020 |
Why?
|
Internal-External Control | 8 | 2016 | 44 | 0.940 |
Why?
|
Prevalence | 25 | 2018 | 1239 | 0.940 |
Why?
|
Antipsychotic Agents | 8 | 2020 | 123 | 0.940 |
Why?
|
Tourette Syndrome | 2 | 2014 | 25 | 0.940 |
Why?
|
Health Behavior | 2 | 2016 | 183 | 0.910 |
Why?
|
Treatment Outcome | 57 | 2020 | 7993 | 0.890 |
Why?
|
Cognition Disorders | 9 | 2016 | 236 | 0.860 |
Why?
|
Motivation | 7 | 2016 | 287 | 0.850 |
Why?
|
Telemedicine | 6 | 2020 | 169 | 0.830 |
Why?
|
Suicide, Attempted | 9 | 2023 | 129 | 0.830 |
Why?
|
Diet | 4 | 2017 | 443 | 0.790 |
Why?
|
Adaptation, Psychological | 8 | 2017 | 157 | 0.780 |
Why?
|
Severity of Illness Index | 24 | 2015 | 1801 | 0.770 |
Why?
|
Diet, Reducing | 14 | 2017 | 31 | 0.770 |
Why?
|
Suicidal Ideation | 4 | 2023 | 67 | 0.760 |
Why?
|
Energy Intake | 13 | 2015 | 98 | 0.750 |
Why?
|
Memory | 8 | 2015 | 225 | 0.740 |
Why?
|
Status Epilepticus | 1 | 2020 | 31 | 0.740 |
Why?
|
Aged | 56 | 2020 | 18415 | 0.730 |
Why?
|
Encephalitis | 1 | 2020 | 104 | 0.720 |
Why?
|
Primary Health Care | 3 | 2010 | 339 | 0.720 |
Why?
|
Self Report | 14 | 2017 | 288 | 0.710 |
Why?
|
Depressive Disorder | 12 | 2014 | 218 | 0.700 |
Why?
|
Prospective Studies | 24 | 2021 | 4213 | 0.690 |
Why?
|
Self-Injurious Behavior | 7 | 2017 | 105 | 0.670 |
Why?
|
Weight Gain | 10 | 2015 | 123 | 0.650 |
Why?
|
Suicide | 4 | 2013 | 139 | 0.640 |
Why?
|
Environment | 7 | 2017 | 219 | 0.640 |
Why?
|
Gastrectomy | 1 | 2018 | 68 | 0.630 |
Why?
|
Psychotropic Drugs | 5 | 2020 | 75 | 0.630 |
Why?
|
Borderline Personality Disorder | 6 | 2020 | 33 | 0.630 |
Why?
|
Reward | 1 | 2019 | 181 | 0.620 |
Why?
|
Personality Inventory | 17 | 2014 | 108 | 0.620 |
Why?
|
Anti-Obesity Agents | 3 | 2016 | 14 | 0.610 |
Why?
|
Seizures | 1 | 2020 | 297 | 0.610 |
Why?
|
Manuals as Topic | 2 | 2011 | 9 | 0.610 |
Why?
|
Nutrition Surveys | 2 | 2017 | 114 | 0.600 |
Why?
|
Interview, Psychological | 14 | 2014 | 69 | 0.600 |
Why?
|
Dissociative Disorders | 2 | 2017 | 9 | 0.600 |
Why?
|
Self Care | 4 | 2016 | 164 | 0.590 |
Why?
|
Running | 3 | 2015 | 25 | 0.590 |
Why?
|
Emergency Service, Hospital | 2 | 2020 | 484 | 0.580 |
Why?
|
Self-Control | 2 | 2016 | 10 | 0.570 |
Why?
|
Depressive Disorder, Major | 4 | 2023 | 158 | 0.570 |
Why?
|
Health Status | 9 | 2013 | 360 | 0.550 |
Why?
|
Mass Screening | 4 | 2017 | 618 | 0.540 |
Why?
|
Life Change Events | 3 | 2015 | 48 | 0.530 |
Why?
|
North Dakota | 8 | 2019 | 10 | 0.520 |
Why?
|
Social Environment | 10 | 2013 | 188 | 0.520 |
Why?
|
Obsessive-Compulsive Disorder | 6 | 2007 | 157 | 0.520 |
Why?
|
Combined Modality Therapy | 17 | 2017 | 1686 | 0.500 |
Why?
|
Patient Satisfaction | 5 | 2011 | 455 | 0.500 |
Why?
|
Shoes | 1 | 2014 | 5 | 0.500 |
Why?
|
Tics | 1 | 2014 | 4 | 0.500 |
Why?
|
Foot Deformities | 1 | 2014 | 6 | 0.500 |
Why?
|
Time Factors | 18 | 2021 | 5210 | 0.490 |
Why?
|
Neuropsychological Tests | 13 | 2016 | 502 | 0.490 |
Why?
|
Dermatologic Surgical Procedures | 2 | 2011 | 16 | 0.490 |
Why?
|
Energy Metabolism | 3 | 2002 | 271 | 0.480 |
Why?
|
Fluoxetine | 5 | 2013 | 42 | 0.480 |
Why?
|
Reproducibility of Results | 23 | 2022 | 2705 | 0.480 |
Why?
|
Body Dysmorphic Disorders | 2 | 2016 | 12 | 0.480 |
Why?
|
Anxiety Disorders | 10 | 2013 | 148 | 0.480 |
Why?
|
Personal Satisfaction | 4 | 2016 | 62 | 0.470 |
Why?
|
Interviews as Topic | 5 | 2011 | 319 | 0.470 |
Why?
|
Epilepsy | 2 | 2020 | 397 | 0.470 |
Why?
|
Metabolic Syndrome | 1 | 2015 | 141 | 0.460 |
Why?
|
Risk Factors | 27 | 2023 | 5417 | 0.460 |
Why?
|
Handwriting | 1 | 2013 | 6 | 0.450 |
Why?
|
Motor Skills Disorders | 1 | 2013 | 15 | 0.450 |
Why?
|
Executive Function | 10 | 2015 | 86 | 0.450 |
Why?
|
Temperament | 5 | 2014 | 26 | 0.440 |
Why?
|
Health Services | 2 | 2010 | 55 | 0.440 |
Why?
|
Circadian Rhythm | 4 | 2010 | 303 | 0.440 |
Why?
|
Cathartics | 5 | 2007 | 27 | 0.430 |
Why?
|
Child Abuse, Sexual | 6 | 2011 | 19 | 0.430 |
Why?
|
Women | 2 | 2011 | 25 | 0.430 |
Why?
|
Diagnosis, Differential | 13 | 2020 | 1565 | 0.420 |
Why?
|
Ethanol | 2 | 2021 | 249 | 0.420 |
Why?
|
Preoperative Period | 6 | 2014 | 91 | 0.420 |
Why?
|
Mental Health Services | 2 | 2004 | 48 | 0.410 |
Why?
|
Calcium Fluoride | 1 | 2011 | 1 | 0.410 |
Why?
|
Dental Caries | 1 | 2011 | 4 | 0.410 |
Why?
|
Mental Health | 1 | 2013 | 162 | 0.410 |
Why?
|
Appetite Depressants | 4 | 2015 | 11 | 0.400 |
Why?
|
Models, Statistical | 6 | 2013 | 574 | 0.400 |
Why?
|
Regression Analysis | 11 | 2015 | 596 | 0.400 |
Why?
|
Self-Assessment | 3 | 2015 | 47 | 0.390 |
Why?
|
United States | 21 | 2021 | 6672 | 0.390 |
Why?
|
Randomized Controlled Trials as Topic | 7 | 2016 | 865 | 0.390 |
Why?
|
Anorexia | 2 | 2012 | 30 | 0.390 |
Why?
|
Cohort Studies | 10 | 2021 | 2767 | 0.390 |
Why?
|
Cross-Sectional Studies | 11 | 2020 | 1621 | 0.380 |
Why?
|
Ecological Momentary Assessment | 4 | 2017 | 25 | 0.380 |
Why?
|
Postoperative Complications | 6 | 2019 | 2207 | 0.380 |
Why?
|
Internet | 3 | 2011 | 312 | 0.370 |
Why?
|
Postoperative Care | 5 | 2017 | 221 | 0.370 |
Why?
|
Gonadal Steroid Hormones | 3 | 2014 | 50 | 0.360 |
Why?
|
Nanoparticles | 1 | 2011 | 157 | 0.360 |
Why?
|
Health Surveys | 6 | 2014 | 239 | 0.350 |
Why?
|
Research Design | 5 | 2007 | 594 | 0.340 |
Why?
|
Self-Help Groups | 3 | 2020 | 14 | 0.330 |
Why?
|
Genome-Wide Association Study | 4 | 2023 | 1621 | 0.320 |
Why?
|
Age Factors | 12 | 2015 | 1851 | 0.320 |
Why?
|
Linear Models | 6 | 2014 | 421 | 0.320 |
Why?
|
Health Care Costs | 2 | 2009 | 238 | 0.320 |
Why?
|
Minnesota | 6 | 2013 | 46 | 0.320 |
Why?
|
Personality Assessment | 12 | 2011 | 98 | 0.320 |
Why?
|
Cyclobutanes | 2 | 2007 | 7 | 0.310 |
Why?
|
Child | 21 | 2021 | 6927 | 0.310 |
Why?
|
Imipramine | 4 | 2002 | 16 | 0.310 |
Why?
|
Genetic Predisposition to Disease | 9 | 2023 | 2271 | 0.310 |
Why?
|
Motor Activity | 3 | 2015 | 327 | 0.310 |
Why?
|
Schizophrenic Psychology | 1 | 2008 | 129 | 0.300 |
Why?
|
Analysis of Variance | 11 | 2016 | 912 | 0.300 |
Why?
|
Antidepressive Agents, Second-Generation | 2 | 2011 | 19 | 0.300 |
Why?
|
Phenotype | 11 | 2019 | 2378 | 0.300 |
Why?
|
Professional-Patient Relations | 3 | 2017 | 53 | 0.300 |
Why?
|
Trichotillomania | 3 | 2011 | 88 | 0.300 |
Why?
|
Affective Symptoms | 4 | 2014 | 47 | 0.290 |
Why?
|
Prognosis | 14 | 2019 | 3679 | 0.290 |
Why?
|
Thinness | 3 | 2012 | 43 | 0.290 |
Why?
|
Satiety Response | 3 | 2005 | 4 | 0.280 |
Why?
|
Escape Reaction | 1 | 2006 | 12 | 0.280 |
Why?
|
Attention | 9 | 2015 | 388 | 0.280 |
Why?
|
Pain Threshold | 3 | 2012 | 58 | 0.280 |
Why?
|
Snacks | 2 | 2016 | 4 | 0.270 |
Why?
|
Factor Analysis, Statistical | 8 | 2016 | 111 | 0.270 |
Why?
|
Adult Survivors of Child Abuse | 2 | 2015 | 10 | 0.270 |
Why?
|
Empirical Research | 3 | 2014 | 19 | 0.270 |
Why?
|
Adolescent Behavior | 3 | 2021 | 106 | 0.260 |
Why?
|
Interpersonal Relations | 5 | 2016 | 170 | 0.260 |
Why?
|
Bipolar Disorder | 1 | 2008 | 377 | 0.260 |
Why?
|
Obsessive Behavior | 3 | 2015 | 8 | 0.260 |
Why?
|
Patient Dropouts | 4 | 2011 | 28 | 0.260 |
Why?
|
Smoking | 2 | 2021 | 609 | 0.250 |
Why?
|
Computers | 1 | 2004 | 112 | 0.250 |
Why?
|
Behavior Therapy | 4 | 2018 | 75 | 0.240 |
Why?
|
Schizophrenia | 1 | 2008 | 464 | 0.240 |
Why?
|
Practice Guidelines as Topic | 3 | 2020 | 1036 | 0.240 |
Why?
|
Disruptive, Impulse Control, and Conduct Disorders | 7 | 2010 | 276 | 0.240 |
Why?
|
Sexual Behavior | 3 | 2008 | 302 | 0.240 |
Why?
|
Laxatives | 2 | 2017 | 13 | 0.240 |
Why?
|
Lactones | 2 | 2016 | 28 | 0.240 |
Why?
|
Sexual Dysfunction, Physiological | 2 | 2014 | 67 | 0.240 |
Why?
|
Sexual Dysfunctions, Psychological | 2 | 2014 | 32 | 0.230 |
Why?
|
Exercise Therapy | 2 | 2016 | 80 | 0.230 |
Why?
|
Incidence | 10 | 2017 | 1577 | 0.230 |
Why?
|
User-Computer Interface | 1 | 2004 | 185 | 0.230 |
Why?
|
Sex Factors | 6 | 2013 | 1054 | 0.230 |
Why?
|
Psychological Tests | 4 | 2013 | 91 | 0.220 |
Why?
|
Patient Selection | 5 | 2014 | 685 | 0.220 |
Why?
|
Electroencephalography | 2 | 2020 | 709 | 0.220 |
Why?
|
Socioeconomic Factors | 4 | 2018 | 567 | 0.220 |
Why?
|
Body Size | 2 | 2013 | 91 | 0.220 |
Why?
|
Psychopathology | 3 | 2016 | 29 | 0.220 |
Why?
|
Rape | 4 | 2003 | 17 | 0.210 |
Why?
|
Menstrual Cycle | 1 | 2002 | 55 | 0.210 |
Why?
|
Genetic Variation | 3 | 2014 | 1351 | 0.210 |
Why?
|
Patient Compliance | 4 | 2017 | 227 | 0.210 |
Why?
|
Social Adjustment | 4 | 2011 | 46 | 0.210 |
Why?
|
Fertility | 1 | 2002 | 115 | 0.210 |
Why?
|
Terminology as Topic | 2 | 2014 | 217 | 0.210 |
Why?
|
Preoperative Care | 4 | 2017 | 397 | 0.200 |
Why?
|
Stress Disorders, Post-Traumatic | 3 | 2012 | 96 | 0.200 |
Why?
|
Meals | 3 | 2016 | 22 | 0.200 |
Why?
|
Computers, Handheld | 3 | 2012 | 32 | 0.200 |
Why?
|
Psychological Trauma | 1 | 2021 | 8 | 0.200 |
Why?
|
Retrospective Studies | 11 | 2020 | 8489 | 0.190 |
Why?
|
Ghrelin | 2 | 2013 | 29 | 0.190 |
Why?
|
Age of Onset | 7 | 2015 | 310 | 0.190 |
Why?
|
Pediatric Obesity | 1 | 2021 | 22 | 0.190 |
Why?
|
Violence | 2 | 2010 | 143 | 0.190 |
Why?
|
England | 1 | 2020 | 41 | 0.190 |
Why?
|
Midwestern United States | 3 | 2016 | 76 | 0.190 |
Why?
|
Hashimoto Disease | 1 | 2020 | 10 | 0.190 |
Why?
|
Leptin | 2 | 2014 | 105 | 0.190 |
Why?
|
Chi-Square Distribution | 2 | 2011 | 364 | 0.190 |
Why?
|
Alcohol Drinking | 2 | 2021 | 267 | 0.180 |
Why?
|
Quantitative Trait Loci | 2 | 2019 | 576 | 0.180 |
Why?
|
Risk-Taking | 4 | 2016 | 148 | 0.180 |
Why?
|
ROC Curve | 3 | 2013 | 752 | 0.180 |
Why?
|
Benzodiazepines | 3 | 2008 | 65 | 0.180 |
Why?
|
Neurology | 1 | 2020 | 70 | 0.180 |
Why?
|
Amenorrhea | 2 | 2013 | 27 | 0.170 |
Why?
|
Lisdexamfetamine Dimesylate | 2 | 2015 | 2 | 0.170 |
Why?
|
Logistic Models | 9 | 2011 | 1186 | 0.170 |
Why?
|
Diuretics | 3 | 2009 | 124 | 0.170 |
Why?
|
Double-Blind Method | 9 | 2015 | 1823 | 0.170 |
Why?
|
Conduct Disorder | 1 | 1999 | 62 | 0.170 |
Why?
|
Commerce | 3 | 2008 | 29 | 0.170 |
Why?
|
Metabolic Diseases | 1 | 2019 | 48 | 0.170 |
Why?
|
Veterans Health | 1 | 2018 | 15 | 0.170 |
Why?
|
Anger | 2 | 2012 | 78 | 0.170 |
Why?
|
Alcohol-Related Disorders | 2 | 2012 | 17 | 0.170 |
Why?
|
Bias | 2 | 2007 | 127 | 0.170 |
Why?
|
Cooperative Behavior | 2 | 2017 | 174 | 0.160 |
Why?
|
Case-Control Studies | 7 | 2021 | 1805 | 0.160 |
Why?
|
Adult Stem Cells | 1 | 2018 | 30 | 0.160 |
Why?
|
Regenerative Medicine | 1 | 2018 | 23 | 0.160 |
Why?
|
Cell- and Tissue-Based Therapy | 1 | 2018 | 49 | 0.160 |
Why?
|
Electrolytes | 2 | 1997 | 52 | 0.160 |
Why?
|
Psychology | 2 | 2015 | 24 | 0.160 |
Why?
|
Pregnancy | 5 | 2020 | 2894 | 0.160 |
Why?
|
Periodicity | 2 | 2009 | 119 | 0.160 |
Why?
|
Emotional Adjustment | 1 | 2017 | 2 | 0.160 |
Why?
|
Food Deprivation | 2 | 2015 | 24 | 0.160 |
Why?
|
Portugal | 1 | 2017 | 21 | 0.160 |
Why?
|
Pneumothorax | 1 | 1998 | 52 | 0.150 |
Why?
|
Hospitals | 1 | 2020 | 294 | 0.150 |
Why?
|
Polymorphism, Single Nucleotide | 8 | 2023 | 2357 | 0.150 |
Why?
|
Negotiating | 1 | 2017 | 19 | 0.150 |
Why?
|
Pilot Projects | 4 | 2015 | 839 | 0.150 |
Why?
|
Risperidone | 2 | 2008 | 23 | 0.150 |
Why?
|
Parents | 3 | 2008 | 272 | 0.140 |
Why?
|
Perfectionism | 1 | 2016 | 1 | 0.140 |
Why?
|
Drug Therapy | 2 | 2006 | 70 | 0.140 |
Why?
|
Fructose | 1 | 2016 | 35 | 0.140 |
Why?
|
Symptom Assessment | 2 | 2013 | 65 | 0.140 |
Why?
|
Attitude to Health | 2 | 2016 | 220 | 0.140 |
Why?
|
Clinical Protocols | 2 | 2011 | 156 | 0.140 |
Why?
|
Memory Disorders | 2 | 2013 | 69 | 0.140 |
Why?
|
Alcoholic Intoxication | 1 | 2016 | 31 | 0.140 |
Why?
|
Wakefulness | 2 | 2007 | 134 | 0.140 |
Why?
|
Medicare | 1 | 2019 | 410 | 0.140 |
Why?
|
Hyperinsulinism | 1 | 2015 | 51 | 0.130 |
Why?
|
Theft | 2 | 2010 | 12 | 0.130 |
Why?
|
Data Collection | 3 | 2006 | 372 | 0.130 |
Why?
|
Aggression | 1 | 1999 | 320 | 0.130 |
Why?
|
Social Identification | 1 | 2015 | 24 | 0.130 |
Why?
|
Emotional Intelligence | 1 | 2015 | 22 | 0.130 |
Why?
|
Delivery of Health Care | 1 | 2020 | 426 | 0.130 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 316 | 0.130 |
Why?
|
Nutritional Status | 1 | 2015 | 83 | 0.130 |
Why?
|
Risk Assessment | 3 | 2017 | 2261 | 0.130 |
Why?
|
Coronavirus Infections | 1 | 2020 | 301 | 0.130 |
Why?
|
Malnutrition | 1 | 2015 | 34 | 0.130 |
Why?
|
Hypoglycemia | 1 | 2015 | 107 | 0.130 |
Why?
|
Publishing | 2 | 2006 | 90 | 0.130 |
Why?
|
Intention to Treat Analysis | 2 | 2013 | 72 | 0.130 |
Why?
|
Warfarin | 1 | 2015 | 103 | 0.130 |
Why?
|
Pain, Postoperative | 1 | 2017 | 240 | 0.130 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2015 | 44 | 0.130 |
Why?
|
Sexuality | 1 | 2014 | 40 | 0.130 |
Why?
|
Complementary Therapies | 2 | 2006 | 54 | 0.130 |
Why?
|
Melanocortins | 1 | 2014 | 4 | 0.120 |
Why?
|
Cystatin C | 1 | 2014 | 31 | 0.120 |
Why?
|
Alkaline Phosphatase | 1 | 2014 | 132 | 0.120 |
Why?
|
Diet Records | 2 | 2011 | 19 | 0.120 |
Why?
|
Nerve Growth Factors | 1 | 2014 | 63 | 0.120 |
Why?
|
Feeding and Eating Disorders of Childhood | 1 | 2013 | 1 | 0.120 |
Why?
|
Femininity | 1 | 2013 | 3 | 0.120 |
Why?
|
Fasting | 1 | 2014 | 161 | 0.120 |
Why?
|
Health Status Indicators | 2 | 2006 | 105 | 0.120 |
Why?
|
Physical Endurance | 1 | 2013 | 9 | 0.120 |
Why?
|
Epoxide Hydrolases | 1 | 2013 | 7 | 0.120 |
Why?
|
Masculinity | 1 | 2013 | 10 | 0.120 |
Why?
|
Self Disclosure | 2 | 2009 | 31 | 0.120 |
Why?
|
Dextroamphetamine | 1 | 2015 | 107 | 0.120 |
Why?
|
Genomics | 1 | 2019 | 720 | 0.120 |
Why?
|
Cues | 1 | 1995 | 175 | 0.120 |
Why?
|
Cause of Death | 2 | 2009 | 277 | 0.120 |
Why?
|
Athletes | 1 | 2013 | 46 | 0.120 |
Why?
|
Overweight | 2 | 2011 | 118 | 0.110 |
Why?
|
Thiophenes | 1 | 2013 | 48 | 0.110 |
Why?
|
Pellagra | 1 | 2013 | 2 | 0.110 |
Why?
|
Psychopharmacology | 1 | 2013 | 26 | 0.110 |
Why?
|
Body Weights and Measures | 1 | 2012 | 27 | 0.110 |
Why?
|
Perceptual Disorders | 1 | 2012 | 12 | 0.110 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2013 | 48 | 0.110 |
Why?
|
Ecology | 1 | 2013 | 74 | 0.110 |
Why?
|
Referral and Consultation | 2 | 2020 | 328 | 0.110 |
Why?
|
Mothers | 2 | 2011 | 141 | 0.110 |
Why?
|
Pain Perception | 1 | 2012 | 18 | 0.110 |
Why?
|
Appetite Regulation | 1 | 2012 | 9 | 0.110 |
Why?
|
Intestinal Absorption | 1 | 2013 | 124 | 0.110 |
Why?
|
Cluster Analysis | 3 | 2010 | 369 | 0.110 |
Why?
|
Analgesics, Opioid | 1 | 2017 | 413 | 0.110 |
Why?
|
Erectile Dysfunction | 1 | 2013 | 74 | 0.110 |
Why?
|
Sleep Apnea Syndromes | 1 | 2013 | 103 | 0.110 |
Why?
|
Counseling | 2 | 2015 | 145 | 0.110 |
Why?
|
Laparoscopy | 2 | 2016 | 754 | 0.110 |
Why?
|
Anticoagulants | 1 | 2015 | 408 | 0.110 |
Why?
|
Predictive Value of Tests | 8 | 2013 | 1673 | 0.100 |
Why?
|
Focus Groups | 1 | 2012 | 155 | 0.100 |
Why?
|
Community Mental Health Services | 2 | 2008 | 15 | 0.100 |
Why?
|
Calcium Hydroxide | 1 | 2011 | 1 | 0.100 |
Why?
|
Genotype | 3 | 2011 | 1851 | 0.100 |
Why?
|
Aging | 2 | 2014 | 691 | 0.100 |
Why?
|
Caloric Restriction | 1 | 2011 | 14 | 0.100 |
Why?
|
Fluorides | 1 | 2011 | 13 | 0.100 |
Why?
|
Ammonium Compounds | 1 | 2011 | 8 | 0.100 |
Why?
|
Methods | 1 | 2011 | 152 | 0.100 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2011 | 79 | 0.100 |
Why?
|
Mental Recall | 4 | 2015 | 159 | 0.100 |
Why?
|
Medical History Taking | 2 | 2015 | 80 | 0.100 |
Why?
|
Particle Size | 1 | 2011 | 122 | 0.100 |
Why?
|
Sertraline | 1 | 2010 | 7 | 0.100 |
Why?
|
Aged, 80 and over | 5 | 2013 | 6509 | 0.100 |
Why?
|
Blood Glucose | 1 | 2015 | 873 | 0.100 |
Why?
|
Reference Values | 4 | 2010 | 674 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 2601 | 0.090 |
Why?
|
Disease Progression | 2 | 2013 | 1531 | 0.090 |
Why?
|
Habits | 1 | 2010 | 15 | 0.090 |
Why?
|
Germany | 4 | 2010 | 72 | 0.090 |
Why?
|
Parent-Child Relations | 2 | 2008 | 77 | 0.090 |
Why?
|
Starvation | 1 | 2010 | 23 | 0.090 |
Why?
|
Blue Cross Blue Shield Insurance Plans | 1 | 2009 | 3 | 0.090 |
Why?
|
Aspartame | 1 | 2009 | 5 | 0.090 |
Why?
|
Drinking | 1 | 2009 | 34 | 0.090 |
Why?
|
Sweetening Agents | 1 | 2009 | 17 | 0.090 |
Why?
|
Utilization Review | 1 | 2009 | 21 | 0.090 |
Why?
|
Inflammation | 1 | 2015 | 920 | 0.090 |
Why?
|
Random Allocation | 3 | 2002 | 332 | 0.090 |
Why?
|
Reproduction | 1 | 2011 | 195 | 0.090 |
Why?
|
Hoarding Disorder | 1 | 2009 | 7 | 0.090 |
Why?
|
Social Support | 1 | 2011 | 193 | 0.090 |
Why?
|
Age Distribution | 1 | 2009 | 204 | 0.090 |
Why?
|
Negativism | 1 | 2008 | 2 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2011 | 381 | 0.090 |
Why?
|
Integrative Medicine | 1 | 2008 | 8 | 0.090 |
Why?
|
Benzhydryl Compounds | 1 | 2008 | 48 | 0.080 |
Why?
|
Data Interpretation, Statistical | 4 | 2013 | 297 | 0.080 |
Why?
|
Caffeine | 1 | 2009 | 81 | 0.080 |
Why?
|
Genetic Association Studies | 1 | 2010 | 294 | 0.080 |
Why?
|
Oxidative Stress | 1 | 2011 | 447 | 0.080 |
Why?
|
Mortality | 1 | 2009 | 149 | 0.080 |
Why?
|
Perinatology | 1 | 2008 | 14 | 0.080 |
Why?
|
Health Expenditures | 1 | 2009 | 86 | 0.080 |
Why?
|
Hospitalization | 1 | 2014 | 849 | 0.080 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2008 | 24 | 0.080 |
Why?
|
Child of Impaired Parents | 1 | 2008 | 19 | 0.080 |
Why?
|
Validation Studies as Topic | 1 | 2007 | 16 | 0.080 |
Why?
|
Statistics as Topic | 4 | 2013 | 238 | 0.080 |
Why?
|
Surgery, Plastic | 1 | 2008 | 42 | 0.080 |
Why?
|
Reaction Time | 3 | 2015 | 309 | 0.080 |
Why?
|
International Cooperation | 1 | 2008 | 127 | 0.080 |
Why?
|
Genetic Linkage | 2 | 2008 | 623 | 0.080 |
Why?
|
Treatment Failure | 2 | 2012 | 285 | 0.080 |
Why?
|
Ipecac | 1 | 2007 | 2 | 0.080 |
Why?
|
Emetics | 1 | 2007 | 4 | 0.080 |
Why?
|
Odds Ratio | 3 | 2012 | 678 | 0.080 |
Why?
|
Recurrence | 4 | 2009 | 1139 | 0.080 |
Why?
|
Postpartum Period | 1 | 2008 | 135 | 0.070 |
Why?
|
Plants, Medicinal | 1 | 2006 | 42 | 0.070 |
Why?
|
Guilt | 2 | 2016 | 11 | 0.070 |
Why?
|
Nutrition Disorders | 1 | 2006 | 16 | 0.070 |
Why?
|
MicroRNAs | 1 | 2011 | 534 | 0.070 |
Why?
|
Transcription Factors | 1 | 2014 | 1565 | 0.070 |
Why?
|
Somnambulism | 1 | 2006 | 1 | 0.070 |
Why?
|
Stomach | 2 | 1997 | 108 | 0.070 |
Why?
|
Endocrine System Diseases | 1 | 2006 | 23 | 0.070 |
Why?
|
Australian Capital Territory | 1 | 2006 | 1 | 0.070 |
Why?
|
Bone Diseases | 1 | 2006 | 54 | 0.070 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2006 | 16 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2011 | 1197 | 0.070 |
Why?
|
Fear | 2 | 2016 | 78 | 0.070 |
Why?
|
Defense Mechanisms | 1 | 2005 | 7 | 0.070 |
Why?
|
Area Under Curve | 3 | 2013 | 334 | 0.070 |
Why?
|
Central Nervous System Stimulants | 1 | 2008 | 216 | 0.070 |
Why?
|
Drugs, Investigational | 1 | 2006 | 37 | 0.070 |
Why?
|
Patient Education as Topic | 3 | 2013 | 351 | 0.070 |
Why?
|
Compulsive Personality Disorder | 1 | 2005 | 16 | 0.070 |
Why?
|
Menarche | 3 | 2011 | 24 | 0.070 |
Why?
|
Phytotherapy | 1 | 2006 | 133 | 0.070 |
Why?
|
Placebos | 4 | 2007 | 218 | 0.070 |
Why?
|
Attitude of Health Personnel | 2 | 2001 | 636 | 0.070 |
Why?
|
Proteins | 1 | 2011 | 777 | 0.070 |
Why?
|
Travel | 1 | 2005 | 68 | 0.070 |
Why?
|
Verbal Behavior | 2 | 2016 | 32 | 0.070 |
Why?
|
Attitude | 1 | 2006 | 127 | 0.060 |
Why?
|
Serotonin Antagonists | 1 | 2005 | 35 | 0.060 |
Why?
|
Gastrointestinal Diseases | 1 | 2006 | 146 | 0.060 |
Why?
|
Quantitative Trait, Heritable | 1 | 2005 | 124 | 0.060 |
Why?
|
Amitriptyline | 1 | 1984 | 11 | 0.060 |
Why?
|
Hypertension | 1 | 2013 | 1141 | 0.060 |
Why?
|
Sleep Wake Disorders | 1 | 2006 | 115 | 0.060 |
Why?
|
Somatoform Disorders | 1 | 2004 | 29 | 0.060 |
Why?
|
Skin Diseases | 1 | 2006 | 166 | 0.060 |
Why?
|
Food | 2 | 2001 | 86 | 0.060 |
Why?
|
Ambulatory Care | 1 | 2005 | 181 | 0.060 |
Why?
|
Child Development | 1 | 1986 | 163 | 0.060 |
Why?
|
Education | 1 | 2004 | 58 | 0.060 |
Why?
|
Lung Diseases | 1 | 2006 | 263 | 0.060 |
Why?
|
Verbal Learning | 2 | 2014 | 30 | 0.060 |
Why?
|
Automobile Driving | 1 | 2004 | 31 | 0.060 |
Why?
|
Multivariate Analysis | 3 | 2011 | 999 | 0.060 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 1373 | 0.060 |
Why?
|
Lithium | 1 | 2003 | 59 | 0.060 |
Why?
|
Anti-Anxiety Agents | 1 | 2003 | 23 | 0.060 |
Why?
|
Drug Delivery Systems | 1 | 2005 | 178 | 0.060 |
Why?
|
Europe | 2 | 2011 | 309 | 0.060 |
Why?
|
Zinc | 1 | 2003 | 91 | 0.060 |
Why?
|
Chronic Disease | 2 | 2020 | 971 | 0.060 |
Why?
|
Gravidity | 1 | 2002 | 7 | 0.050 |
Why?
|
False Positive Reactions | 1 | 2002 | 216 | 0.050 |
Why?
|
Health Promotion | 1 | 2004 | 160 | 0.050 |
Why?
|
Personality Tests | 2 | 2014 | 21 | 0.050 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2002 | 19 | 0.050 |
Why?
|
Genetic Loci | 1 | 2023 | 250 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2005 | 394 | 0.050 |
Why?
|
Cross-Over Studies | 1 | 2003 | 399 | 0.050 |
Why?
|
Truth Disclosure | 1 | 2002 | 87 | 0.050 |
Why?
|
Risk | 2 | 1999 | 674 | 0.050 |
Why?
|
Patient Care Team | 2 | 2002 | 280 | 0.050 |
Why?
|
Narcissism | 1 | 2001 | 4 | 0.050 |
Why?
|
Infertility, Female | 1 | 2002 | 93 | 0.050 |
Why?
|
Juvenile Delinquency | 1 | 2001 | 27 | 0.050 |
Why?
|
Pregnancy Complications | 1 | 2004 | 336 | 0.050 |
Why?
|
Child Welfare | 1 | 2001 | 39 | 0.050 |
Why?
|
Chlorides | 1 | 2001 | 103 | 0.050 |
Why?
|
Tooth Erosion | 2 | 1991 | 3 | 0.050 |
Why?
|
Single-Blind Method | 1 | 2001 | 153 | 0.050 |
Why?
|
Prejudice | 1 | 2001 | 49 | 0.050 |
Why?
|
Outpatients | 1 | 2001 | 94 | 0.050 |
Why?
|
Body Temperature Regulation | 2 | 1995 | 56 | 0.050 |
Why?
|
Pregnancy Outcome | 1 | 2002 | 247 | 0.050 |
Why?
|
Tobacco Products | 1 | 2021 | 41 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 3362 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 1961 | 0.050 |
Why?
|
Sodium | 1 | 2001 | 341 | 0.050 |
Why?
|
Rural Population | 1 | 2001 | 136 | 0.050 |
Why?
|
Software | 1 | 2004 | 654 | 0.050 |
Why?
|
Clinical Trials as Topic | 3 | 1993 | 1169 | 0.050 |
Why?
|
Infant | 3 | 2013 | 3046 | 0.050 |
Why?
|
Research Personnel | 1 | 2000 | 67 | 0.050 |
Why?
|
Drug Monitoring | 1 | 2000 | 118 | 0.040 |
Why?
|
Urban Population | 1 | 2001 | 213 | 0.040 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 1999 | 24 | 0.040 |
Why?
|
Cystic Fibrosis | 1 | 2000 | 112 | 0.040 |
Why?
|
Students | 1 | 2001 | 147 | 0.040 |
Why?
|
Algorithms | 1 | 2007 | 1830 | 0.040 |
Why?
|
Anticonvulsants | 1 | 2020 | 126 | 0.040 |
Why?
|
Fluvoxamine | 1 | 1998 | 6 | 0.040 |
Why?
|
Demography | 1 | 1999 | 177 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2006 | 827 | 0.040 |
Why?
|
Educational Status | 3 | 2011 | 188 | 0.040 |
Why?
|
Pain | 1 | 2021 | 391 | 0.040 |
Why?
|
Kansas | 1 | 2018 | 6 | 0.040 |
Why?
|
Arrhythmias, Cardiac | 1 | 1980 | 187 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2013 | 454 | 0.040 |
Why?
|
Physician's Role | 1 | 2000 | 179 | 0.040 |
Why?
|
Perception | 1 | 1999 | 168 | 0.040 |
Why?
|
Medical Records | 2 | 2011 | 119 | 0.040 |
Why?
|
Population Surveillance | 1 | 1999 | 219 | 0.040 |
Why?
|
Veterans | 1 | 2018 | 72 | 0.040 |
Why?
|
Personality Development | 3 | 2001 | 23 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2012 | 1991 | 0.040 |
Why?
|
Machine Learning | 1 | 2020 | 232 | 0.040 |
Why?
|
Object Attachment | 1 | 2017 | 20 | 0.040 |
Why?
|
Superior Mesenteric Artery Syndrome | 1 | 1997 | 3 | 0.040 |
Why?
|
Gastric Dilatation | 1 | 1997 | 3 | 0.040 |
Why?
|
Individuality | 1 | 1998 | 109 | 0.040 |
Why?
|
Epidemiologic Factors | 1 | 1996 | 5 | 0.040 |
Why?
|
Child, Preschool | 3 | 2013 | 3612 | 0.040 |
Why?
|
Canada | 1 | 1996 | 204 | 0.040 |
Why?
|
Research | 1 | 2017 | 253 | 0.030 |
Why?
|
Hostility | 1 | 2016 | 24 | 0.030 |
Why?
|
Mass Media | 1 | 2015 | 26 | 0.030 |
Why?
|
Potassium | 1 | 1997 | 281 | 0.030 |
Why?
|
International Normalized Ratio | 1 | 2015 | 38 | 0.030 |
Why?
|
Nutritional Requirements | 1 | 2015 | 17 | 0.030 |
Why?
|
Diet Surveys | 1 | 2015 | 20 | 0.030 |
Why?
|
Nutrition Policy | 1 | 2015 | 12 | 0.030 |
Why?
|
Micronutrients | 1 | 2015 | 17 | 0.030 |
Why?
|
Biomarkers | 1 | 2001 | 1718 | 0.030 |
Why?
|
Vagus Nerve | 1 | 1995 | 45 | 0.030 |
Why?
|
Nociceptors | 1 | 1994 | 29 | 0.030 |
Why?
|
Agouti-Related Protein | 1 | 2014 | 4 | 0.030 |
Why?
|
Receptor, trkB | 1 | 2014 | 3 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2015 | 190 | 0.030 |
Why?
|
Lithium Carbonate | 1 | 1993 | 8 | 0.030 |
Why?
|
Pandemics | 1 | 2020 | 740 | 0.030 |
Why?
|
Psychotherapy, Brief | 1 | 1993 | 10 | 0.030 |
Why?
|
Mental Status Schedule | 1 | 2013 | 26 | 0.030 |
Why?
|
Duloxetine Hydrochloride | 1 | 2013 | 2 | 0.030 |
Why?
|
Brain | 1 | 2004 | 2216 | 0.030 |
Why?
|
Genotyping Techniques | 1 | 2014 | 68 | 0.030 |
Why?
|
Half-Life | 1 | 2013 | 96 | 0.030 |
Why?
|
Metabolic Clearance Rate | 1 | 2013 | 121 | 0.030 |
Why?
|
Physicians | 1 | 2001 | 673 | 0.030 |
Why?
|
Sex Distribution | 1 | 2013 | 173 | 0.030 |
Why?
|
Motivational Interviewing | 1 | 2013 | 18 | 0.030 |
Why?
|
Social Behavior | 1 | 2016 | 294 | 0.030 |
Why?
|
Evidence-Based Practice | 1 | 2013 | 45 | 0.030 |
Why?
|
Protein Kinases | 1 | 2014 | 209 | 0.030 |
Why?
|
Pain Measurement | 1 | 1994 | 321 | 0.030 |
Why?
|
Social Class | 1 | 2013 | 128 | 0.030 |
Why?
|
Adipose Tissue | 1 | 1995 | 240 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 526 | 0.030 |
Why?
|
Diagnostic Self Evaluation | 1 | 2012 | 12 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2014 | 302 | 0.030 |
Why?
|
Naltrexone | 1 | 1993 | 135 | 0.030 |
Why?
|
Recovery of Function | 1 | 2013 | 272 | 0.030 |
Why?
|
Forecasting | 1 | 2013 | 304 | 0.030 |
Why?
|
bcl-2-Associated X Protein | 1 | 2011 | 47 | 0.030 |
Why?
|
Drive | 1 | 2011 | 3 | 0.030 |
Why?
|
Colic | 1 | 2011 | 7 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2014 | 428 | 0.030 |
Why?
|
Administration, Oral | 1 | 2013 | 684 | 0.030 |
Why?
|
Arousal | 1 | 1992 | 170 | 0.030 |
Why?
|
Choice Behavior | 1 | 2013 | 160 | 0.030 |
Why?
|
Ataxia Telangiectasia Mutated Proteins | 1 | 2011 | 52 | 0.030 |
Why?
|
Monitoring, Ambulatory | 1 | 2011 | 32 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2011 | 151 | 0.030 |
Why?
|
Cholesterol | 1 | 2013 | 356 | 0.030 |
Why?
|
History, 20th Century | 1 | 2013 | 312 | 0.030 |
Why?
|
Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2011 | 41 | 0.020 |
Why?
|
Walking | 1 | 2011 | 87 | 0.020 |
Why?
|
Breast Feeding | 1 | 2011 | 91 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 2011 | 193 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2011 | 199 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2011 | 159 | 0.020 |
Why?
|
Epigenomics | 1 | 2011 | 100 | 0.020 |
Why?
|
North America | 1 | 2011 | 180 | 0.020 |
Why?
|
Community Health Planning | 1 | 2010 | 21 | 0.020 |
Why?
|
Cross-Cultural Comparison | 1 | 2010 | 34 | 0.020 |
Why?
|
Language | 1 | 2011 | 151 | 0.020 |
Why?
|
Desipramine | 1 | 1989 | 9 | 0.020 |
Why?
|
Selection Bias | 1 | 1989 | 37 | 0.020 |
Why?
|
Monoamine Oxidase Inhibitors | 1 | 1989 | 6 | 0.020 |
Why?
|
Nortriptyline | 1 | 1989 | 6 | 0.020 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2010 | 50 | 0.020 |
Why?
|
Insulin | 1 | 2015 | 1160 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2013 | 492 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2011 | 279 | 0.020 |
Why?
|
DNA Damage | 1 | 2011 | 366 | 0.020 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2011 | 183 | 0.020 |
Why?
|
Awareness | 1 | 2010 | 93 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2011 | 266 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2009 | 63 | 0.020 |
Why?
|
Nutrition Assessment | 1 | 2009 | 21 | 0.020 |
Why?
|
Phosphorylation | 1 | 2011 | 1106 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2011 | 388 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2011 | 306 | 0.020 |
Why?
|
Nuclear Family | 1 | 2008 | 92 | 0.020 |
Why?
|
Waiting Lists | 1 | 2009 | 175 | 0.020 |
Why?
|
Databases, Factual | 1 | 2011 | 814 | 0.020 |
Why?
|
Cost of Illness | 1 | 2009 | 150 | 0.020 |
Why?
|
Haplotypes | 1 | 2010 | 642 | 0.020 |
Why?
|
Self Efficacy | 1 | 2008 | 53 | 0.020 |
Why?
|
Behavior, Addictive | 1 | 2010 | 130 | 0.020 |
Why?
|
Protein Binding | 1 | 2011 | 1456 | 0.020 |
Why?
|
Self Medication | 1 | 2007 | 6 | 0.020 |
Why?
|
Self Administration | 1 | 2007 | 73 | 0.020 |
Why?
|
Time | 1 | 2007 | 77 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 860 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2011 | 1135 | 0.020 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 1986 | 19 | 0.020 |
Why?
|
Women's Health | 1 | 2007 | 100 | 0.020 |
Why?
|
Family | 1 | 1988 | 311 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2011 | 1208 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2008 | 238 | 0.020 |
Why?
|
Receptors, Dopamine | 1 | 2005 | 38 | 0.020 |
Why?
|
Receptors, Serotonin | 1 | 2005 | 34 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2011 | 3092 | 0.020 |
Why?
|
Tomography, Emission-Computed | 1 | 2004 | 103 | 0.020 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2004 | 92 | 0.010 |
Why?
|
Blood Urea Nitrogen | 1 | 1983 | 34 | 0.010 |
Why?
|
Work | 1 | 2003 | 16 | 0.010 |
Why?
|
Heart Function Tests | 1 | 1983 | 30 | 0.010 |
Why?
|
Blood Cell Count | 1 | 1983 | 79 | 0.010 |
Why?
|
Gastrointestinal Motility | 1 | 1983 | 25 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2005 | 751 | 0.010 |
Why?
|
Respiratory Function Tests | 1 | 1983 | 136 | 0.010 |
Why?
|
Kidney Function Tests | 1 | 1983 | 123 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2004 | 162 | 0.010 |
Why?
|
Hormones | 1 | 1983 | 141 | 0.010 |
Why?
|
Discriminant Analysis | 1 | 2002 | 66 | 0.010 |
Why?
|
Drug Utilization | 1 | 2003 | 65 | 0.010 |
Why?
|
Serotonin | 1 | 2004 | 218 | 0.010 |
Why?
|
Drug Interactions | 1 | 2003 | 248 | 0.010 |
Why?
|
Food, Formulated | 1 | 2002 | 24 | 0.010 |
Why?
|
Videotape Recording | 1 | 2001 | 47 | 0.010 |
Why?
|
Mandatory Reporting | 1 | 2001 | 7 | 0.010 |
Why?
|
Social Control, Formal | 1 | 2001 | 12 | 0.010 |
Why?
|
Syndrome | 1 | 2002 | 446 | 0.010 |
Why?
|
Infant, Newborn | 1 | 1986 | 2379 | 0.010 |
Why?
|
Probability | 1 | 2000 | 355 | 0.010 |
Why?
|
Photic Stimulation | 1 | 2001 | 493 | 0.010 |
Why?
|
Mice | 1 | 2011 | 11352 | 0.010 |
Why?
|
Electrocardiography | 1 | 1980 | 478 | 0.010 |
Why?
|
Sampling Studies | 1 | 1997 | 70 | 0.010 |
Why?
|
Barium Sulfate | 1 | 1997 | 43 | 0.010 |
Why?
|
Animals | 1 | 2011 | 26582 | 0.010 |
Why?
|
Observer Variation | 1 | 1993 | 602 | 0.010 |
Why?
|
Survival Analysis | 1 | 1993 | 1538 | 0.010 |
Why?
|